RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk (Q37625447)
Jump to navigation
Jump to search
scientific article published on February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk |
scientific article published on February 2014 |
Statements
1 reference
RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk (English)
1 reference
Paul D Miller
1 reference
Claus Christiansen
1 reference
Nadia S Daizadeh
1 reference
Luanda Grazette
1 reference
Mary S Anthony
1 reference
Ogo Egbuna
1 reference
Andrea Wang
1 reference
Suresh R Siddhanti
1 reference
Nathalie Franchimont
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference